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The relationship between induced hypothyroidism and adrenal involution has been studied b:· a variet:· of approaches in an attempt to
elucidate the physiological basis between the events. McCarthy ct al.
( 19.59) reported on an investigation of feeding several antithyroidal
agents to rats to study adrenal gland involution. While adrenal involution did occur following treatment with several of the goitrogens.
only in one case was there a difference in peripheral plasma adrenal
corticoid levels. In rats fed p-aminobenzoic acid ( PABA) for 12
weeks. peripheral levels of corticosterone' ( B) decreased and levels
of a Porter-Silber positive chromogen increased markedly. Work from
the laboratories of Peron ( 1961) and of Birmingham ( 1961) established that the Porter-Silber chromogen in rat blood is 18-hydroxydeoxycorticosterone ( 18-OH DOC). Cortes and Peron ( 1964) compared adrenal venous effiuent of normal and PABA-tested rats. These
workers concluded that adrenal venous secretion of B and of 18-OH
DOC by PABA-treated rats was unchanged from control values.
Since the level of PABA fed has been shown to decrease thyroid
function ( McCarthy and Murphree, 1960). a question arose as to
whether adrenal tissue from these hypothyroid rats would show any
modification in corticosteroidogenesis.
This study was undertaken to
examine adrenal corticoid conversion in adrenal glands from rats
fed PABA for various periods of time.
MATERIALS AND METHODS
Male Holtzman rats, 1:30 to 140 grams body weight, were housed
.5 to 10 animals per colony cage under conditions of controlled light
( 14 hours light - 10 hours dark) and temperature ( 72cF). All animals
"Supported by NIH grant AM-05744
1 The systematic
nomenclature of compounds for which trivial names are used
in this report are: Corticosterone ( B ), 11,8, 21-clihyclroxy-4-pregnen-.3,20-dione;
18-hvclroxy-deoxycorticosterone
( 18- OH DOC), 18, 21-dihvclroxy-4-pregnen-.3,
20-dione; pregnenolone, .3-hydroxy-5-pregnen-20-one;
progesterone, 4-pregnen-.3,
20-dione; 11-deoxycorticosterone, 21-hydroxy-4-pregnen-.3, 20-dione; G-6-P, glucose-6-phosphate.
•
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were given tap water to drink ad libitum. Control rats were fed ground
Purina rat food while experimental animals received the ground food
containing 2% or 4% PABA by weight. For each experiment, 14 to 18
rats were used for each control or treatment group.
Rats were treated for periods of 2 to 12 weeks then killed by decapitation. Adrenal glands were rapidly removed and stored on filter
paper moistened with 0.25 M sucrose and maintained in a cold chamber. The glands were cleaned of adhering fat, weighed, then homogenized in 0.2,5 M sucrose. In the first experiments, amounts of homogenates equivalent to 20 mg wet weight adrenal gland per 0.3 ml homogenate were incubated in NaHCO" buffer 20 mM, with KCl 7.7
mM, 800 µ,g reduced nicotinamide adenine dinucleotide phosphate
( NADPH) or an NADPH generating system ( glucose-6-phosphate,
2.1 mg and NADP 1.8 mg). Pregnenolone or progesterone 60 µ,g in
0.02 ml of an ethanol-propylene glycol mixture 1: 1 was added as
precursor steroid. Total volume of the incubation mixture was brought
to 2.0 ml with 0.1.54 M NaCl.
In other experiments, 11-deoxycorticosterone (DOC) was added as
precursor corticoid to examine 11,8-hydroxylation reactions. Incubations Wt're carried out in a manner as outlined above except that the
buffer was Tris 20 mM. The conversion of DOC into corticosterone
! B) was supported by adding NADPH 800 µ,g and calcium ions
( Ca 2 - 11 m~f ) or by oxidizable intermediates such as malate, isocitrate,
etc. 10 m\1.
All incubations were carried out at 37°C in a Dubnoff metabolic incubator for :30 to 60 minutes. Steroid analyses were carried out on
dichloromethane extracts of aliquots of the incubation media. Conversion of pregnenolone or progesterone to a-ketols was measured by the
blue tetrazolium method of Elliott et al. ( 1954). Corticosterone determinations were carried out fluorometrically using the method of
Moncloa et al. ( 1959).
RESULTS
The first experiments concerned evaluating the effects of length of
PABA treatment on the ability of adrenal homogenate preparations
to convert pregnenolone or progesterone into corticoid product ( Table
1). These studies were carried out in the absence of Ca2+, hence the
primary a-ketol product was DOC. The administration of 2%PABA to
rats for 10 weeks had little effect to alter the conversion of precursor
pregnenolone or progesterone to DOC ( Table 1, Treatment 1). With
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the PABA 4% treatment for ,5 or 6 weeks, NADPH supported conversion of pregnenolone was some 20% below control values. In the same
preparations, however, with glucose-6-phosphate and NADP, the tissue
from the experimental groups showed generally the same or greater
levels of conversion of pregnenolone or progesterone compared to
controls. After 8 or 12 weeks of 4% PABA administration, adrenal tissue from the experimental animals showed a markedly reduced ability to convert either precursor steroid ( Table I).
A comparison was made of the ability of adrenal homogenate from
normal and PABA-fed rats to convert pregnenolone or progesterone
into DOC and B ( Table 2). In the presence of NADPH to support the
conversion, the primary product was DOC, with, as expected, more
product a1ising from progesterone than from pregnenolone. While
TABLE 1
Comparison of the Ahility of Adrenal Homogenate from Normal and
P ABA-Treated Rats to Convert Pregnern1lone or Progesterone
into Blue Tetrazolium PositiYe Corticoid Product

TREAT:\!E'.\T
---

I

II
III
I\'

,-

-----

Control
PABA 2,;-10 wks.
Control
P ABA 4%-.5 wks.
Control
P ABA 4%-6 wks.
Control
P ABA 4%-8 wks.
Control
PABA 4%-12 wks.
TREAT:\!E1'"T

I

II

IV

µ.,g corticoid/ 10 mg adrenal tissue"
Additions with Pregnenolone as Steroid Substrate
NADPH
G-6-P+
800 µ.,g
NADP

Control
2% PABA-10 wks.
Control
4% PABA-6 wks.
Control
4% PABA-8 wks.

22.5
19.4
27.2
22.6
27.1
2:3.l
:3,5.9
24.6
16.l
10.9

2:3.:3
25.0
29.9
:3.'3.9
25.:3
26.9
.52..5
40.8

Additions with Progesterone
NADPH
800 µ.,g
14.9
19.2
27.1
25.7
42.2
:36.0

"Incubations carried out for 60 minutes in NAHCO
Corticoid detennined by blue tetrazolium reaction.

as Steroid Substrate
G-6-P+
:\"AD
15.:3
17.7
25.:3
28.8
:36.8
26.7

3

20 mM as indicated in text
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the levels of DOC production were comparable for controls and either
experimental group, the DOC values for the PABA-treated groups
were slightly but consistently above control. With oxidizable substrates ( Table 2) precursor conversion was lower than with NADPH;
however, B was the major corticoid product. There was a tendency
for PABA-treatment to be associated with a decrease in substrate
supported conversion of DOC, produced from pregnenolone or progesterone, into B. The total production of DOC + B from progesterone
in the presence of malate was 9.7, 10.5 and 10.7 µ,g/10 mg tissue for
control, 2% PABA and 4% PABA groups respectively. In the same
groups, DOC production was 1.6, 1.8 and 6.6 µ,g/10 mg tissue respectively. Thus the PABA treatment appears i.o be associated with a reduced in vitro conversion of DOC into B by adrenal homogenate.
The influence of PABA treatment on adrenal 11{3-hydroxylation was
indicated clearly by the lowered adrenal conversion of DOC into B
( Table 3). In the presence of NADPH and Ca2+ llmM, B production
by adrenal tissue from 2% PABA fed rats was l to 4 µ,g/10 mg tissue
lower than control values; with the 4% PABA group there was a 33%
reduction in in vitro DOC conversion. The most marked changes in
11[3-hydroxylation occurred in experimental preparations when in vitro
steroid conversions were supported by oxidizable intermediates ( Table
3). In the tissue from the 2% PABA treated rats there were decreases
in substrate-supported
conversions of DOC into B, but results were
variable. However, with the 4% PABA treated groups there was up to
a 50% decrease in B production in the presence of isocitrate, malate
or a-ketogluterate.

DISCUSSION
It is generally accepted that hypothyroidism is associated with a
decreased metabolism reflected both at the organismic and cellular
level. The data reported by McCarthy and Murphree ( 1960) note that
administration of PABA under conditions identical to those used in
this study produced a decreased thyroidal 131-1 uptake. In terms of
the dose of PABA used in this investigation, the 4%treatment was generally associated with a greater reduction in in vitro corticoid conversions than was 2% PABA ( Tables 1, 2, 3). With the 4% PABA,
however, consistent effects on decreasing steroid precursor conversions
were noted only after 8 weeks of treatment. Previous study ( McCarthy and Murphree, 1960) indicated that 4%PABA was a much more
effective agent than was the 2% diet. While some evidence of thyroid

B
0.7
3.30
2.9
2.5

---

DOC
12.1
0.0
0.0
0.0.'3

B
0.9
2.9
3.4
2.3

PRECNENOLONE
2% PABA

---------

or Progesterone into DOC

DOC
11.l
0.01
0.6
1.1

B
0.6
2.5
2.5
2.4

4%PABA
DOC
18.5
0.8
1.2
1.6

Control
B
0.9
6.,'3
2.1
8.1

2.4
:30.1
1:3.1
fi.0
17.9

1.7
29.2
1:3.9
fi.2
10.9

2.9
21.1
8.0
4.:3
8.9

Expt. I
Control 2% PABA n 4% PABA

-----

1.9
26.(i
19.2
12.fi

2.fi
:31.2
27.9
27.0

Control
2.0
:33.0
:34.0
27.9

4% PABA

Expt. II
2% PABA

2.8
:34_0

Control

µ,g Corticosterone/ 10 mg Adrenal Tissue

B
0.9
5.4
1.7
(i,6

2.1
:30.:l

2.0
22.2

Expt. III
2% PABA 4% PABA

B
0.9
6.0
2.7
8.7

4% PABA
DOC
20.9
2.2
2.1
4.1

• lnculJations carried out in a total volume of 2.0 ml containing Tris lmffPr ( 20 ml\1) pl! 7.4, DO~~ (i0 µ,g, pvridine nudeotidPs 800
µ,g, and Ca2+ 11 mM or substrate 10 mM.
0 Adrenal tissue obtained from rats fed PABA for 12 weeks.

NADPH
NADPH + Ca2t llml\f
Isocitrate
a-Ketogluterate
Malate

DOC, 60 µ,g plus

Ad di ti on

==============~~===-'-'--'c__c_-

TABLE 3
Conversion of DOC into Corticosterone by Adrenal
Homogenate in the Presence of NADPH or Metabolic Intermediate•

DOC
20,1
1.7
1.7
1.8

PROCESTERONE
2%PABA

TABLE 2
B_by Adrenal Homogenates of Normal and Goitrogen-Trea_ted Rats

+

Adrenal tissue was obtained from rats fed PABA for 12 weeks with comparable untreated control rats.
Incubations carried out for 60 min. in NAH 2 CO" buffer as indicated in text.

DOC
10.7
0.0
0.0
0.0

Prduct µ,g/10 mg
NADPH
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Succinate
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inhibition was found in rats fed 2% PABA for 2 or 4 weeks, the later
workers found adrenal 32-P incorporation and decreased inorganic
phosphorus to be unchanged from control levels. Thyroid inhibition,
decreased adrenal 32-P and lower adrenal inorganic phosphorus and
adrenal atrophy were found in rats with 4% P ABA administered for 12
weeks. Thus it is to be expected that marked changes would occur
with the 4% experimental diet after 4 or more weeks of feeding.
The general results of this study suggest an impairment in the production and/or utilization of NADPH, in reactions associated with
mitochondria in adrenal tissue of PABA-fed rats. These changes contribute to the decreased in vitro ll/3-hydroxylation in the adrenal
homogenate from the treated groups.
Adrenal preparations from rats treated for 5 or 6 weeks were found
to show lower conversions of pregnenolone in the presence of NADPH
while conversion of the precursor with G-6-P and NADP was unimpaired. The conversion of pregnenolone to progesterone is known
to require oxidized P:Tidine nucleotide, NAD or NADP ( Talalay 1957,
Gagliano 1967), while the 21-hydroxylation of progesterone into DOC
requires NADPH ( Ryan and Engle, 1956). Incubation of adrenal
homogenate with NADH has been shown to suppress the conversion
of pregnenolone to progesterone unless oxidation of the co-factor can
be effected ( Koritz 1962, 1963). It may be that after 6 weeks of PABA
treatment, the reduced in vitro conversion of pregnenolone with
NADPH ( hut not with G-6-P + NADP) could reflect reduced oxidation of NADPH to NAD. It is to be noted, however, that in the same
tissue preparation ( ,5, 6 weeks PABA, Table 1) progesterone hydroxylation in vitro in the presence of NADPH was but slightly affected by
the goitrogen diet. It may well have been that alternate mechanisms
for NADPH oxidation were reduced in the homogenate prepared from
experimental animals. Adrenal tissue from rats given experimental
diet for 8 weeks or longer did show reduced steroid conversions in the
presence of either NADPH or G-6-P + NAD.
In rat adrenal mitochondria, Peron, Guerra and McCarthy ( 196,5)
demonstrated that conversion of DOC into B in the presence of
NADPH required high levels of calcium ions ( Ca 2 +). The effect of
Ca2+ was noted to bring about mitochondrial swelling to facilitate
NADPH entry to the hydroxylating enzyme system. The data noted
in Table 2 support the suggestion that exogenous NADPH can support the conversion of pregnenolone to progesterone as well as the
subsequent 21-hydroxylation of the latter steroid to DOC by tissue
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from normal and PABA-treated rats. There was, however, little conversion of DOC into B in the presence of NADPH alone.
The ability of oxidizable substrate to support adrenal mitochondrial
11,8-hydroxylation has been demonstrated by Brownie and Grant
( 19.54), Harding et al. ( 1965), Guerra, Peron and McCarthy ( 1966),
Cammer and Estabrook ( 1967) and many others. These substrates
are seen to be oxidized to generate intramitochond!'ial '.',.IADPH to
provide reducing equivalent to the cytochrome Pm chain to support
hydroxylation reactions ( Harding, Wong and Nelson 1964, Guerra,
Peron, and McCarthy 1966, and Cammer and Estabrook, 1967).
The studies carried out to provide the data for Table 2 lead to the
conclusion that adrenal tissue from PABA-treated rats shows a reduced 11,8-hydroxylation of DOC. Though the study was carried out
with adrenal homogenate so that substrates such as isocitrate were exposed to cytosol enzymes, there was primarily a conversion of pregnenolone or progesterone into B, ( controls, Table 2). \Vith the experimental tissue, however, there was generally a decrease in B production with an increase in DOC accumulation. The fact that DOC
was formed indicates that the substrates can be oxidized to generate
NADPH for the microsomal 21-hvdroxvlation to form DOC. The microsomal hydroxylation reactions also involve cytochrome P,,,, ( Omura
et al., 1965). In all cases for 4% PABA, DOC fonnation with substrates was greater than control tissue. While these data mav reflect
normal mitochondrial oxidation of substrate there is evidence for decreased 11,8-hydroxylation in homogenate from PABA-treated rats.
The results noted in Table :3 support the suggestion that there is a
reduction in oxidation of substrates to generate NADPH and/or cofactor utilization to support the conversion of DOC into B in adrenal
tisue from PABA rats. It is of interest to note that with Ca 2 - 11
mM + NADPH, B production b~- experimental group adrenal tissue
was markedly decreased. Studies have been reported on 11,8-hydroxylation by rat adrenal mitochondria relating the role of substrate utilization ( Guerra, Peron and McCarthy, 1966) and effect of Ca'- on
substrate supported DOC h~·droxylation ( Peron, McCartlff and Guerra, 1966). These reports noted that either isocitrate or Ca'- 11 +
NADPH supported maximum conversion of DOC into B. Addition of
Ca 2 + 11 mM to isocitrate ( or other substrates) acted to swell mitochondria and inhibit substrate utilization. Under the latter conditions,
where substrate use was suppressed by Ca 2 +, addition of NADPH supported maximum 11,8-hydroxylation ( Peron, McCarth~- and Guerra,
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1966). The findings reported here suggest that while substrate oxiNADPH ( Table 3)
dation may be decreased, the data on Ca2+
suggests decreased 11,B-hydroxylation may also occur. These findings
will have to he confirmed in adrenal mitochondria where effect of
PABA treatment on 11,B-hydroxylation and cytochrome P450can be
evaluated.
\Vhile the most marked effect of the experimental treatment was
noted on DOC conversion, decreased conversions of pregnenolone
and progesterone were also observed in adrenal homogenate from
rats on PABA for 12 weeks. Freedland and Murad ( 1969) studied
effects of thyroxine and thyroidectomy on rat adrenal enzymes. These
workers found that thyroidectomy had little effect on most enzymes
( as isocitrate dehydrogenase) but increased malic enzyme activity.
Since the latter study was carried out in the supematent of a 20,000 X
.e: sedinwntation of adrenal homogenate, the results, therefore, reflect cytosol enzvmes rather than mitochondrial enzymes. The data
presented here thus lead to the suggestion that the decreased corticoid production is a change reflecting decreased mitochondrial oxidation metabolism involving generation or utilization of NADPH.
These findings of reduced in vitro B formation appear to be in opposition to the report of Cortes and Peron ( 1964) who found that
adrenal B and 18-OHDOC secretion in PABA-treated rats was unchanged from control animals. While conversion mechanism could be
such that in vitro reactions would be lowered, in vivo control might
bring about conditions for normal svnthesis and release. Steinetz and
Beach ( 196:3) reported that rats tr~ated with thiouracil show normal
response to ACTH in viw but in vitro evidence of increased adrenal
responsiveness to ACTH was noted. The findings reported here need
to be confirmed in adrenal mitochondria and microsomal preparations
,,·ith additional studies on ACTH responsiveness in vitro.
During the course of this study plasma samples of PABA treated
rats were subjected to 18-OHDOC determination of Cortes, Peron and
Dorfman ( 1963). In agreement with prior report of McCarthy et al.
( 19.59), the levels of Porter-Silber positive components on peripheral
plasma of rats given 4% PABA for 12 weeks was 4 to 6 times above
normal expected values. At the same time, however, in agreement
with the report of Cortes and Peron ( 1964), adrenal vein secretion of
18-OHDOC in PABA-fed rats was unchanged from control. It may
,,·ell be that the high level of Porter-Silber positive material in the
systemic blood of PABA-treated rats may reflect altered peripheral

+
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that this Porter-Silber

SUMMARY
Adrenal homogenate obtained from rats fed PABA for periods up
to 12 weeks evidenced decreased in i;itro adrenal corticoid conversion.
While conversion of pregnenolone or progesterone appeared suppressed following treatment, a more pronounced effect on DOC conversion was noted. The response to added oxidizable substrate or
NADPH suggested that co-factor generation and/or utilization was
suppressed. Some evidence for decreased use of NADPH for 11,8hvdroxvlation was found.
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Studies of the fine structure of .5 da:' old cysticercoids of H. diminuta revealed nucleoli with well-formed lamellae in germinal cells
within the body of the encysted worm. The nucleoli were located
centrall:' in the nucleus and appeared not to be attached to the chromosomes, chromatin, or to the nuclear envelope.
A few nucleoli possess nucleolar material attached at their surfaces
as lamellae ( Fig. 1). The lamellae measure about 60 to 80 mµ, in diameter and may arise by splitting from the central bodies of the nucleoli. Occasionally a lamella is branched and appears to communicate with the scattered pars amorpha.
Porter ( 19.54, J. Histochem. Cytochem. 2: 346-3,5.5; 1960, Fourth
internat. Conference on Electron Microscopy, eds. Bargmann :\follenstedt, Niehrs, Peters, Ruska and Wolpers, Berlin-Gi:ittingen-Heidelberg: Springer) reported lamellae in striated muscle of A111bystoma
larva, and Beams and Seklon ( 1968, Zeit. f. Zellforsch. 8.5: 237-242)
found lamellae in oocytes of centipedes and cra: fish. The latter
0

F1G. 1.
diminuta.

Nucleoli from germinal

cell of 5 da\· old cvsticercoid

Hymenolepi,
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authors suggested that the lamellae may function to transfer material
between nucleoli.
Nucleoli are believed to function as depositories for ribonuclear
genetic materials that are reworked and elaborated for cytoplasmic use.
They appear to originate in association with certain chromosomes and
they are more or less constant in number for given somatic cell types
( Moses, 1964, Cytology and Cell Physiology, ed. by Bourne, 3 ed.
Academic Press, New York).
Kaulenas, Foor and Fairbairn ( 1969 Science 163: 1201-1202) reported the presence of nucleoli in 4-celled Ascaris embryos that were
associated with the synthesis of rRNA. These authors showed an increase in the numbers of nucleoli and the nucleoli exhibited lamellae.
The above evidence indicates that the presence of lamellae, like
the increased numbers of nucleoli, are more related to increased
RNA production than to transfering of materials between nucleoli.
I would like to thank Dr. Chauncey G. Goodchild, Department of
Biology, Emory University, for his support and encouragement on
this project.

